Violet Therapeutics
PrivateLast Round
Seed
May 13, 2026
Total Funding Raised
$15.35M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Violet Therapeutics is a biotechnology company that develops first-in-class small molecule therapies for neurodegenerative diseases by utilizing a proprietary platform to map disease-relevant cell-to-cell signaling interactions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Violet Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Violet Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 13, 2026 | ||||
| Seed | May 31, 2023 |
Violet Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ono Venture Investment, Inc. | Seed |
| SV Health Investors | Seed |
| UTEC (The University of Tokyo Edge Capital Partners) | Seed |
| Mass General Brigham Innovation | Seed |
| Ono Venture Investment, Inc. | Seed |
| OVI Partners | Seed |
| LifeSpan Vision Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
$4.75M round led by LifeSpan Vision Ventures.
- May 31, 2023
$11M round led by Mass General Brigham Innovation and SV Health Investors.
Violet Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Violet Therapeutics's valuation, stock price, and market status.